Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep M Gatell

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|January 10, 2016
Backbones versus core agents in initial ART regimens: one game, two playersJosep M Llibre, Sharon Walmsley, Josep M Gatell
Human Vaccines & Immunotherapeutics|May 29, 2012
Therapeutic vaccines against HIV infectionFelipe García, Agathe León, Josep M Gatell, et al.
Expert Review of Vaccines|April 23, 2017
New challenges in therapeutic vaccines against HIV infectionLorna Leal, Constanza Lucero, Josep M Gatell, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 11, 2005
[Clinical and epidemiological study of a series of HIV-infected patients over 50 years old]Esperança Antón, Montserrat Sala, Josep Mallolas, et al.
AIDS (London, England)|March 3, 2006
Transmission of HIV-1 from an obstetrician to a patient during a caesarean sectionJosep Mallolas, Mireia Arnedo, Tomás Pumarola, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCGNarcís Saubi, Ester Gea-Mallorquí, Pau Ferrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretroviralsOscar Miró, Sònia López, Esteban Martínez, et al.
HIV Clinical Trials|January 14, 2017
Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudyMaria Saumoy, Juan M Tiraboschi, Jordi Ordoñez-Llanos, et al.
AIDS (London, England)|April 8, 2015
Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patientsAgathe León, Lorna Leal, Berta Torres, et al.
AIDS Research and Human Retroviruses|September 1, 2005
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscleOscar Miró, Sònia López, Joaquim Fernández-Solà, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|January 10, 2016
Backbones versus core agents in initial ART regimens: one game, two playersJosep M Llibre, Sharon Walmsley, Josep M Gatell
Human Vaccines & Immunotherapeutics|May 29, 2012
Therapeutic vaccines against HIV infectionFelipe García, Agathe León, Josep M Gatell, et al.
Expert Review of Vaccines|April 23, 2017
New challenges in therapeutic vaccines against HIV infectionLorna Leal, Constanza Lucero, Josep M Gatell, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 11, 2005
[Clinical and epidemiological study of a series of HIV-infected patients over 50 years old]Esperança Antón, Montserrat Sala, Josep Mallolas, et al.
AIDS (London, England)|March 3, 2006
Transmission of HIV-1 from an obstetrician to a patient during a caesarean sectionJosep Mallolas, Mireia Arnedo, Tomás Pumarola, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCGNarcís Saubi, Ester Gea-Mallorquí, Pau Ferrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretroviralsOscar Miró, Sònia López, Esteban Martínez, et al.
HIV Clinical Trials|January 14, 2017
Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudyMaria Saumoy, Juan M Tiraboschi, Jordi Ordoñez-Llanos, et al.
AIDS (London, England)|April 8, 2015
Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patientsAgathe León, Lorna Leal, Berta Torres, et al.
AIDS Research and Human Retroviruses|September 1, 2005
Short communication: HIV infection, antiretrovirals, and apoptosis: studies on skeletal muscleOscar Miró, Sònia López, Joaquim Fernández-Solà, et al.
Pageof 7